144 related articles for article (PubMed ID: 36901860)
1. Influence of Genetic Variations in miRNA and Genes Encoding Proteins in the miRNA Synthesis Complex on Toxicity of the Treatment of Pediatric B-Cell ALL in the Brazilian Amazon.
da Silva Menezes E; de Moraes FCA; de Nazaré Cohen-Paes A; Wanderley AV; Pereira EEB; Pastana LF; Modesto AAC; de Assumpção PP; Burbano RMR; Dos Santos SEB; Dos Santos NPC; Fernandes MR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901860
[TBL] [Abstract][Full Text] [Related]
2. Influence of variants of the
de Souza TP; de Carvalho DC; Wanderley AV; Fernandes SM; Rodrigues JCG; Cohen-Paes A; Fernandes MR; Mello Junior FAR; Pastana LF; Vinagre LWMS; Silva ALDC; de Assumpção PP; Santos S; Khayat AS; Dos Santos NPC
Am J Transl Res; 2020; 12(12):8216-8224. PubMed ID: 33437394
[TBL] [Abstract][Full Text] [Related]
3. Association between SNPs in microRNAs and microRNAs-Machinery Genes with Susceptibility of Leprosy in the Amazon Population.
da Silva MNS; da Veiga Borges Leal DF; Sena C; Pinto P; Gobbo AR; da Silva MB; Salgado CG; Dos Santos NPC; Dos Santos SEB
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142557
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia.
López-López E; Gutiérrez-Camino Á; Piñán MÁ; Sánchez-Toledo J; Uriz JJ; Ballesteros J; García-Miguel P; Navajas A; García-Orad Á
PLoS One; 2014; 9(3):e91261. PubMed ID: 24614921
[TBL] [Abstract][Full Text] [Related]
5. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.
Gutierrez-Camino Á; Umerez M; Lopez-Lopez E; Santos-Zorrozua B; Martin-Guerrero I; de Andoin NG; Ana S; Navajas A; Astigarraga I; Garcia-Orad A
Pharmacogenomics; 2018 Dec; 19(18):1403-1412. PubMed ID: 30479191
[TBL] [Abstract][Full Text] [Related]
6. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.
Gutierrez-Camino A; Oosterom N; den Hoed MAH; Lopez-Lopez E; Martin-Guerrero I; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; Heil SG; García-Orad A; van den Heuvel-Eibrink MM
Pharmacogenet Genomics; 2017 Aug; 27(8):303-306. PubMed ID: 28628559
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility.
Gutierrez-Camino A; Lopez-Lopez E; Martin-Guerrero I; Piñan MA; Garcia-Miguel P; Sanchez-Toledo J; Carbone Bañeres A; Uriz J; Navajas A; Garcia-Orad A
Pediatr Res; 2014 Jun; 75(6):767-73. PubMed ID: 24618566
[TBL] [Abstract][Full Text] [Related]
8. Association between the
Cardoso de Carvalho D; Pereira Colares Leitão L; Mello Junior FAR; Vieira Wanderley A; Souza TP; Borges Andrade de Sá R; Cohen-Paes A; Rodrigues Fernandes M; Santos S; Salim Khayat A; Pimentel de Assumpção P; Pereira Carneiro Dos Santos N
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32992962
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an admixed population in the Brazilian Amazon.
de Carvalho DC; Wanderley AV; Dos Santos AMR; Fernandes MR; Cohen Lima de Castro AN; Leitão LPC; de Carvalho JAN; de Souza TP; Khayat AS; Dos Santos SEB; de Assumpção PP; Dos Santos NPC
Leuk Res; 2018 Nov; 74():10-13. PubMed ID: 30269037
[TBL] [Abstract][Full Text] [Related]
10. MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.
Iparraguirre L; Gutierrez-Camino A; Umerez M; Martin-Guerrero I; Astigarraga I; Navajas A; Sastre A; Garcia de Andoin N; Garcia-Orad A
Pharmacogenet Genomics; 2016 Nov; 26(11):517-525. PubMed ID: 27649261
[TBL] [Abstract][Full Text] [Related]
11. The Role of
Fernandes SSM; Leitão LPC; Cohen-Paes AN; Gellen LPA; Pastana LF; de Carvalho DC; Modesto AAC; da Costa ACA; Wanderley AV; Lima CHV; Pereira EEB; Fernandes MR; Burbano RMR; de Assumpção PP; Santos SEBD; Santos NPCD
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456416
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity.
Gutierrez-Camino A; Umerez M; Santos B; Martin-Guerrero I; García de Andoin N; Sastre A; Navajas A; Astigarraga I; Garcia-Orad A
Epigenomics; 2018 Apr; 10(4):409-417. PubMed ID: 29569486
[TBL] [Abstract][Full Text] [Related]
13. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.
Umerez M; Garcia-Obregon S; Martin-Guerrero I; Astigarraga I; Gutierrez-Camino A; Garcia-Orad A
Pharmacogenomics; 2018 Mar; 19(4):361-373. PubMed ID: 29469670
[TBL] [Abstract][Full Text] [Related]
14. Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Zehtab S; Sattarzadeh Bardsiri M; Mirzaee Khalilabadi R; Ehsan M; Fatemi A
BMC Res Notes; 2022 Feb; 15(1):46. PubMed ID: 35164849
[TBL] [Abstract][Full Text] [Related]
15. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
[TBL] [Abstract][Full Text] [Related]
16. Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.
Gabor KM; Schermann G; Lautner-Csorba O; Rarosi F; Erdelyi DJ; Endreffy E; Berek K; Bartyik K; Bereczki C; Szalai C; Semsei AF
Pediatr Blood Cancer; 2015 Apr; 62(4):622-8. PubMed ID: 25557962
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia.
Chaber R; Gurgul A; Tabarkiewicz J; Wróbel G; Szmatoła T; Jasielczuk I; Haus O; Lejman M; Rybka B; Ryczan-Krawczyk R; Jaśkowiec A; Paszek S; Potocka N; Arthur CJ; Bal W; Łach K; Kowal A; Zawlik I; Latos-Grażyńska E
Adv Clin Exp Med; 2022 Mar; 31(3):293-305. PubMed ID: 35092653
[TBL] [Abstract][Full Text] [Related]
18. A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report.
Hasani SS; Hashemi M; Eskandari-Nasab E; Naderi M; Omrani M; Sheybani-Nasab M
Tumour Biol; 2014 Jan; 35(1):219-25. PubMed ID: 23888320
[TBL] [Abstract][Full Text] [Related]
19. MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers.
Bandeira IC; Vieira IA; Andreis TF; Brussa Reis L; Macedo GS; Vianna FSL; Santos-Silva P; Palmero EI; Galvão HCR; Ramos CRN; Santiago KM; Achatz MI; da Costa AABA; Ashton-Prolla P
Cancer Genet; 2020 Jan; 240():54-58. PubMed ID: 31778928
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
